These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26645213)

  • 21. Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
    Johannson KA; Strâmbu I; Ravaglia C; Grutters JC; Valenzuela C; Mogulkoc N; Luppi F; Richeldi L; Wells AU; Vancheri C; Kreuter M;
    Lancet Respir Med; 2017 Jul; 5(7):591-598. PubMed ID: 28664861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.
    Tobin RW; Pope CE; Pellegrini CA; Emond MJ; Sillery J; Raghu G
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1804-8. PubMed ID: 9847271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Gastroesophageal Reflux in Patients With Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
    Fidler L; Sitzer N; Shapera S; Shah PS
    Chest; 2018 Jun; 153(6):1405-1415. PubMed ID: 29559309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comorbidities of IPF: How do they impact on prognosis.
    Torrisi SE; Vancheri A; Pavone M; Sambataro G; Palmucci S; Vancheri C
    Pulm Pharmacol Ther; 2018 Dec; 53():6-11. PubMed ID: 30193867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
    Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
    BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
    Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
    Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic pulmonary fibrosis: Clinical behavior and aging associated comorbidities.
    Buendía-Roldán I; Mejía M; Navarro C; Selman M
    Respir Med; 2017 Aug; 129():46-52. PubMed ID: 28732835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of patients with erosive and nonerosive GERD in high-Helicobacter-pylori prevalence region.
    Jonaitis LV; Kiudelis G; Kupcinskas L
    Dis Esophagus; 2004; 17(3):223-7. PubMed ID: 15361095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosis.
    Sokai A; Handa T; Tanizawa K; Oga T; Uno K; Tsuruyama T; Kubo T; Ikezoe K; Nakatsuka Y; Tanimura K; Muro S; Hirai T; Nagai S; Chin K; Mishima M
    Respir Res; 2015 Sep; 16():120. PubMed ID: 26415518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis.
    García-Sancho C; Buendía-Roldán I; Fernández-Plata MR; Navarro C; Pérez-Padilla R; Vargas MH; Loyd JE; Selman M
    Respir Med; 2011 Dec; 105(12):1902-7. PubMed ID: 21917441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Change in serum marker of oxidative stress in the progression of idiopathic pulmonary fibrosis.
    Matsuzawa Y; Kawashima T; Kuwabara R; Hayakawa S; Irie T; Yoshida T; Rikitake H; Wakabayashi T; Okada N; Kawashima K; Suzuki Y; Shirai K
    Pulm Pharmacol Ther; 2015 Jun; 32():1-6. PubMed ID: 25862941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic pulmonary fibrosis: evolving concepts.
    Ryu JH; Moua T; Daniels CE; Hartman TE; Yi ES; Utz JP; Limper AH
    Mayo Clin Proc; 2014 Aug; 89(8):1130-42. PubMed ID: 24867394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori, obesity and gastro-oesophageal reflux disease: is there a relation?
    Kiewiet RM; van Vliet AC
    Neth J Med; 2006 Apr; 64(4):131-2. PubMed ID: 16609163
    [No Abstract]   [Full Text] [Related]  

  • 35. Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial.
    Raghu G; Pellegrini CA; Yow E; Flaherty KR; Meyer K; Noth I; Scholand MB; Cello J; Ho LA; Pipavath S; Lee JS; Lin J; Maloney J; Martinez FJ; Morrow E; Patti MG; Rogers S; Wolters PJ; Yates R; Anstrom KJ; Collard HR
    Lancet Respir Med; 2018 Sep; 6(9):707-714. PubMed ID: 30100404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-parietal cell autoimmunity is associated with an accelerated decline of lung function in IPF patients.
    Beltramo G; Thabut G; Peron N; Nicaise P; Cazes A; Debray MP; Joannes A; Castier Y; Mailleux AA; Frija J; Pradère P; Justet A; Borie R; Dombret MC; Taille C; Aubier M; Crestani B
    Respir Med; 2018 Feb; 135():15-21. PubMed ID: 29414448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study.
    Morell F; Villar A; Montero MÁ; Muñoz X; Colby TV; Pipvath S; Cruz MJ; Raghu G
    Lancet Respir Med; 2013 Nov; 1(9):685-94. PubMed ID: 24429272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B; McColl K
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():32-40. PubMed ID: 16042657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum CA 15-3 is increased in pulmonary fibrosis.
    Ricci A; Mariotta S; Bronzetti E; Bruno P; Vismara L; De Dominicis C; Laganà B; Paone G; Mura M; Rogliani P; Mastrangeldo M; Sciacchitano S; Saltini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):54-63. PubMed ID: 19960789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clusters of comorbidities in idiopathic pulmonary fibrosis.
    Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Rasmussen F; Bendstrup E
    Respir Med; 2021; 185():106490. PubMed ID: 34130097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.